Interestingly, pretreatment of NSCLC cells with EFNA1 ligand prior to IR also partially reduced DNA-PKcs S2056 phosphorylation and accordingly phosphorylation of its downstream targets, i.e., KAP1 and RPA32. This evidence concerns the gene EFNA1 and non-small cell lung carcinoma.